Evaluate the Effects of Repeated Periods of Modified Fasting to Support Healthy Natural Weight Management and Prevention of Weight Gain

Having smoked any cigarette, electronic cigarette, cigar, pipe, or used a recreational drug in the past 30 days

History of allergy or sensitivity to any component of the study products including milk, soy and almonds

Donation of blood with 30 days prior to screening/baseline

Inability to provide a venous blood sample

Participation in another study within 30 days prior to baseline/screening

Being pregnant or planning on becoming pregnant during study participation; or breast feeding

Having been diagnosed, received medical treatment or taking medication daily for the following medical condition(s):

Diabetes mellitus

Eating disorder

Acute or chronic inflammatory disease or autoimmune disease

Cardiovascular disease

Gastrointestinal disease including gallbladder problems, gallstones or biliary tract obstruction

Thyroid disease (unless on a stable dose of medication for 3 months prior to screening and unlikely to change medication or dose during the study)

Hypertension (unless on a stable dose of medication for 3 months prior to screening and unlikely to change medication or dose during the study)

Psychiatric disorder

Neurologic condition/disease

Cancer (unless skin cancer other than melanoma which has been treated \> 3 years prior to Baseline/screening)

Active or chronic liver, pancreatic and kidney disease

Blood coagulation disorder

Other condition or medication use that would preclude participation in the study in the judgment of the investigator/sub-investigator (Sub-I)

Currently taking or having taken within the 30 days prior to screening/baseline any hormone replacement therapy (including DHEA (dehydroepiandrosterone), estrogen, progesterone, or testosterone; except those utilized as a method of birth control and which have been taken for \> 3 months, with no anticipated change for the duration of the study)

Currently taking any of the nutritional supplements used in the study and unwilling to discontinue use at least 14 days prior to screening.

Currently taking a medication or nutritional supplement specifically for weight loss and unwilling to discontinue use 14 days prior to the first dosing of study supplements

Currently participating in a weight loss program and unwilling to discontinue participation prior to enrollment into the study

Currently taking an anti-coagulant, anti-platelet medication or a glucose lowering medication

Having had a surgical procedure or having an internal medical device which, in the judgment of the PI/Sub-I, would preclude participation in the study

Having abnormal screening laboratory test values including bilirubin \> 2.5 x ULN (upper limit of normal), AST/SGOT(aspartate aminotransferase/serum glutamin oxaloacetic transaminase) and ALT/SGPT (alanine aminotransferase/serum glutamic pyruvic transaminase) \> 2.5 x ULN, serum creatinine \> 1.5 mg/dL, blood glucose \< 85 mg/dL or \> 125 mg/dL, and TSH(thyroid stimulating hormone) \> 4.12 µIU/mL, or other lab test result(s) that would preclude study participation in the judgement of the PI/Sub-I

Having blood pressure readings at Baseline/screening \> 140 systolic or \> 90 diastolic on two consecutive readings unless permitted to proceed to the next visit in the judgment of the PI/Sub-I

Currently consumes more than 7 standard alcoholic drinks per week for women and 14 drinks per week for men (a standard alcoholic drink is defined as one bottle/can of beer, one glass of wine, or one ounce of hard liquor)

Unable or unwilling to avoid consuming grapefruit juice or fresh grapefruit, Seville oranges and tangelos

Having any other circumstance that precludes study participation in the judgment of the PI/Sub-I including use of other nutritional supplements which will be evaluated on a case-by-case basis.

What this study is about